⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Tillotts Pharma AG and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Tillotts Pharma AG
↗Rheinfelden, Switzerland
Tillotts Pharma AG is a fast-growing international specialty pharmaceutical company headquartered in Rheinfelden, Switzerland. The company is dedicated to the development, in-licensing, and marketing of innovative pharmaceutical products, with a primary focus on gastroenterology and infectious diseases.
Since 2009, Tillotts has been a subsidiary of the Japanese Zeria Group. The company operates through a network of European affiliates and global partners, marketing products in over 65 countries to improve patient outcomes in areas such as inflammatory bowel disease (IBD), ulcerative colitis, Crohn's disease, and Clostridioides difficile infection.
CLASSIFICATION
SIZE & FINANCIALS
Employees:201-500
Revenue:$300M
Founded:1998
Ownership:subsidiary
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Zeria Pharmaceutical Co., Ltd.
Acquired By:Zeria Pharmaceutical Co., Ltd. (2009-01-01)
Subsidiaries:Tillotts Pharma Czech s.r.o., Tillotts Pharma France SAS, Tillotts Pharma GmbH, Tillotts Pharma UK Ltd, Tillotts Pharma Ltd (Ireland), Tillotts Pharma Italy Srl, Tillotts Pharma Spain S.L.U.
Key Partnerships:Zeria Group (Parent/R&D), Various academic institutions and GI-focused marketing partners worldwide
COMPETITION
Position:Niche Player
Competitors:SLA Pharma, UCB, Takeda
LEADERSHIP
Key Executives:
Thomas A. Tóth von Kiskér - CEO
Harald Haubitz - Chair of Senior Management Committee
Johannes Spleiss - Head of R&D, Medical Affairs, Drug Safety and Regulatory Affairs
LINKS
Website:tillotts.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Tillotts Pharma AG. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.